A risky fight for survival

Andrea Sloan is dying of ovarian cancer. She's seeking "compassionate use" of a new drug that's not FDA-approved, but a drug maker says it's too risky.

Source: http://rss.cnn.com/~r/rss/cnn_health/~3/7IMFrlpaCdU/index.html

view view site view website home